<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr J</journal-id><journal-id journal-id-type="iso-abbrev">Nutr J</journal-id><journal-title-group><journal-title>Nutrition Journal</journal-title></journal-title-group><issn pub-type="epub">1475-2891</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27543277</article-id><article-id pub-id-type="pmc">4991057</article-id><article-id pub-id-type="publisher-id">195</article-id><article-id pub-id-type="doi">10.1186/s12937-016-0195-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>Almond supplementation reduces serum uric acid in coronary artery disease patients: a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jamshed</surname><given-names>Humaira</given-names></name><address><email>humaira.jamshed@aku.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gilani</surname><given-names>Anwar-ul-Hassan</given-names></name><address><phone>+92 21 34864571</phone><email>anwar.gilani@aku.edu</email><email>anwarhgilani@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sultan</surname><given-names>Fateh Ali Tipoo</given-names></name><address><email>fatehali.tipoo@aku.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Amin</surname><given-names>Faridah</given-names></name><address><email>faridah.amin@aku.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arslan</surname><given-names>Jamshed</given-names></name><address><email>jamshed.arsalan@aku.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghani</surname><given-names>Sumaira</given-names></name><address><email>dr.sumaira@live.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Masroor</surname><given-names>Madiha</given-names></name><address><email>madiha_1063@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan </aff><aff id="Aff2"><label>2</label>Pakistan Council for Science and Technology, Government of Pakistan, Shahara-i-Jamhuriat, G-5/2, Islamabad, Pakistan </aff><aff id="Aff3"><label>3</label>Department of Medicine, Aga Khan University, Karachi, Pakistan </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>15</volume><elocation-id>77</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>2</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">Elevated serum uric acid (UA), a biomarker of renal insufficiency, is also an independent prognostic marker for morbidity in coronary artery disease (CAD) and poses serious health risks. This study reports the effect of almond consumption on UA in CAD patients.</p></sec><sec><title>Study design</title><p id="Par2">A randomized controlled clinical trial was conducted with three groups: no-intervention (NI), Pakistani almonds (PA) or American almonds (AA). Patients were recruited from the Cardiology Clinics, Aga Khan University Hospital. Two follow-ups were scheduled at week-6 and week-12. 150 patients were randomly divided in three groups (50 per group). NI was not given almonds, whereas the PA and AA were given Pakistani and American almond varieties (10&#x000a0;g/day), respectively; with instruction to soak overnight and eat before breakfast.</p></sec><sec><title>Results</title><p id="Par3">Almonds supplementation significantly reduced (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) serum UA among groups, and over time. At week-6, UA concentrations were -13 to -16&#x000a0;% less in PA and AA; at week-12 the concentrations were -14 to -18&#x000a0;% less, compared to NI. Systolic and diastolic blood pressure and body weights of the participants remained fairly constant among all the groups.</p></sec><sec><title>Conclusion</title><p id="Par4">Almonds (10&#x000a0;g/day), eaten before breakfast, reduces serum UA in CAD patients. Prevention of hyperuricemia can confer protection from kidney and vascular damage and if extrapolated for general population, dietary almonds can offer grander health benefit. Trial is registered at Australian New Zealand Clinical trial registry as ACTRN12614000036617.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Hyperuricemia</kwd><kwd>Coronary artery disease</kwd><kwd>Nuts</kwd><kwd>Soaked almonds</kwd><kwd>Low dose</kwd></kwd-group><funding-group><award-group><funding-source><institution>Higher Education Commission, Pakistan (PK)</institution></funding-source><award-id>Indigenous PhD scholarship</award-id><principal-award-recipient><name><surname>Jamshed</surname><given-names>Humaira</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par5">There has been considerable increase in global prevalence of hyperuricemia, in the past few years, backed by western dietary patterns. Where higher serum uric acid (UA) frequently indicates renal insufficiency [<xref ref-type="bibr" rid="CR1">1</xref>], it may also be associated with coronary artery disease (CAD) [<xref ref-type="bibr" rid="CR2">2</xref>], and deliberated as a prognostic marker for morbidity and mortality, independent of other risk factors [<xref ref-type="bibr" rid="CR3">3</xref>]. Even in patients with no history of heart disease or stroke, elevated UA was associated with higher risk of myocardial infarction or stroke [<xref ref-type="bibr" rid="CR4">4</xref>]. An increase in serum UA by 1&#x000a0;mg/dL contributes to 12&#x000a0;% increase in risk of CAD death [<xref ref-type="bibr" rid="CR5">5</xref>]. This association is believed to be stronger in women than men [<xref ref-type="bibr" rid="CR5">5</xref>]. But there are also some indications where, in middle-aged men, hyperuricemia served as a risk factor for cardiovascular and all-cause mortality [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par6">UA is shown to possess anti-oxidant potential [<xref ref-type="bibr" rid="CR7">7</xref>], which undermines its causative role in chronic diseases. Yet, its establishment as a comorbid risk marker is backed by recent meta-analysis [<xref ref-type="bibr" rid="CR8">8</xref>] and systemic review [<xref ref-type="bibr" rid="CR5">5</xref>] showing significant correlation between hyperuricemia and CAD. Further signifying its role for cardiovascular health, are the studies where anti-hypertensive and/or lipid-neutralizing therapies limited UA production, thereby reducing CAD mortality [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par7">Almonds are among the nuts approved by Food and Drug Administration &#x02013; United States to have the potential of reducing CVD risk [<xref ref-type="bibr" rid="CR11">11</xref>]. The lipid-neutralizing properties, among others, have been extensively elaborated [<xref ref-type="bibr" rid="CR12">12</xref>]. Dietary supplementation of almonds is shown to prevent hyperuricemia in a cardiovascular disease rat model [<xref ref-type="bibr" rid="CR13">13</xref>]. This study inspects the UA-reducing potential of almond supplementation in CAD patients.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Study population</title><p id="Par8">Hundred and fifty CAD patients were recruited from Cardiology Clinic at The Aga Khan University Hospital, Karachi. The eligibility criteria and trial logistics have previously been defined in detail, following the CONSORT guidelines [<xref ref-type="bibr" rid="CR14">14</xref>]. Briefly, patients consuming nuts on regular basis (&#x0003e;15&#x000a0;g/d; three days/week) or those having nut allergies were excluded. Informed consent was obtained. Using block randomization, patients were assigned any of the following three groups: No Intervention (NI); Intervention with Pakistani almonds (PA) or American almonds (AA).</p></sec><sec id="Sec4"><title>Study design</title><p id="Par9">Approval was obtained from Ethical Review Committee of The Aga Khan University, Karachi, Pakistan (Application ID: 2230-Med-ERC-12), and the trial was registered at Australian New Zealand Clinical Trial Registry (ID: ACTRN12614000036617).</p><p id="Par10">Baseline blood was drawn and vitals (body weight, blood pressure etc.) were recorded. Participants of NI were instructed not to consume any nuts, specifically almonds, during their enrollment in trial; whereas participants of PA and AA were given almonds (10&#x000a0;g/day), with the instruction to consume in a traditional way (i.e. soak overnight, peel and eat before breakfast in the morning). Diaries, to record almond consumption, were provided. Compliance was monitored through regular phone calls (twice per week). Follow-up visits were scheduled at week-6 and week-12 (&#x000b1;3&#x000a0;days), at which blood samples were collected and vitals were recorded. Participants of NI received almonds after the completion of trial.</p><p id="Par11">Pakistani almonds, namely Talwar, grown in Balochistan &#x02013; Pakistan; and imported American almonds, locally available at Utility stores in Karachi, were used. Serum concentration of uric acid (UA) was measured on Roche Cobass c-111 automated analyzer using commercially available kit (Uric acid kit no. 4657608190).</p><p id="Par12">Data were analyzed on SPSS version 17.0 and Graphpad Prism, and results are presented as means&#x02009;&#x000b1;&#x02009;SEM. Two-way repeated measures ANOVA was used to compare means of groups followed by Bonferroni post-tests. For categorical data, chi-square test was used to compare differences between groups. <italic>P</italic>-value&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant (95&#x000a0;% Confidence interval).</p></sec></sec><sec id="Sec5" sec-type="results"><title>Results</title><p id="Par13">The flow of participants through the trial, as per CONSORT format, has been reported previously [<xref ref-type="bibr" rid="CR14">14</xref>]. Attrition rate was around 15&#x000a0;%. The major reasons included: failure to contact (<italic>n</italic>&#x02009;=&#x02009;20); leaving city in summer vacations (<italic>n</italic>&#x02009;=&#x02009;8); and a few cases of angioplasty (<italic>n</italic>&#x02009;=&#x02009;3). The baseline characteristics of participants in each group, is provided in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Systolic and diastolic BP and body weight of the participants remained fairly constant (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) throughout the twelve weeks of the study, as seen in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics of CAD patients randomized into no-intervention, Pakistani almond or American almond groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">No Intervention<sup>1</sup>
</th><th colspan="2">Pakistani Almonds<sup>1</sup>
</th><th colspan="2">American Almonds<sup>1</sup>
</th></tr><tr><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th></tr></thead><tbody><tr><td>Age, years</td><td>61</td><td>0.2</td><td>57</td><td>1.6</td><td>61</td><td>1.5</td></tr><tr><td colspan="7">Gender</td></tr><tr><td>&#x02003;Male, <italic>n</italic>
</td><td>39</td><td/><td>36</td><td/><td>38</td><td/></tr><tr><td>&#x02003;Female, <italic>n</italic>
</td><td>11</td><td/><td>14</td><td/><td>12</td><td/></tr><tr><td>Body weight, kg</td><td>73.4</td><td>0.2</td><td>79</td><td>1.9</td><td>75</td><td>1.6</td></tr><tr><td>Blood Pressure, mmHg</td><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x02003;Systolic</td><td>127</td><td>0.4</td><td>126</td><td>2.4</td><td>128</td><td>2.6</td></tr><tr><td>&#x02003;Diastolic</td><td>70</td><td>0.2</td><td>67</td><td>1.2</td><td>68</td><td>1.3</td></tr><tr><td colspan="7">Serum Uric Acid, mg/dL</td></tr><tr><td>&#x02003;Male</td><td>7.2</td><td>0.49</td><td>6.9</td><td>0.23</td><td>6.8</td><td>0.22</td></tr><tr><td>&#x02003;Female</td><td>5.9</td><td>0.34</td><td>5.7</td><td>0.14</td><td>5.6</td><td>0.21</td></tr></tbody></table><table-wrap-foot><p>
<sup>1</sup>
<italic>n</italic>&#x02009;=&#x02009;50 per group</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Blood pressure and serum uric acid concentrations of CAD patients randomized into no-intervention (NI), Pakistani almonds (PA) and American Almonds (AA) groups, at week-6 and week 12</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="2"/><th colspan="4">No Intervention</th><th colspan="4">Pakistani Almonds</th><th colspan="4">American Almonds</th></tr><tr><th colspan="2">Male</th><th colspan="2">Female</th><th colspan="2">Male</th><th colspan="2">Female</th><th colspan="2">Male</th><th colspan="2">Female</th></tr><tr><th colspan="2">
<italic>n</italic>&#x02009;=&#x02009;25</th><th colspan="2">
<italic>n</italic>&#x02009;=&#x02009;9</th><th colspan="2">
<italic>n</italic>&#x02009;=&#x02009;27</th><th colspan="2">
<italic>n</italic>&#x02009;=&#x02009;11</th><th colspan="2">
<italic>n</italic>&#x02009;=&#x02009;33</th><th colspan="2">
<italic>n</italic>&#x02009;=&#x02009;8</th></tr><tr><th colspan="2"/><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th></tr></thead><tbody><tr><td colspan="14">Blood Pressure</td></tr><tr><td>&#x02003;Systolic, mmHg</td><td>Week 6</td><td>128</td><td>0.5</td><td>129</td><td>0.6</td><td>126</td><td>1.7</td><td>127</td><td>0.9</td><td>127</td><td>1.7</td><td>126</td><td>1.4</td></tr><tr><td/><td>Week 12</td><td>126</td><td>1.2</td><td>127</td><td>0.5</td><td>124</td><td>3.1</td><td>126</td><td>1.2</td><td>125</td><td>3.4</td><td>125</td><td>0.5</td></tr><tr><td>&#x02003;Diastolic, mmHg</td><td>Week 6</td><td>71</td><td>0.3</td><td>69</td><td>0.4</td><td>67</td><td>0.5</td><td>68</td><td>0.5</td><td>67</td><td>0.2</td><td>66</td><td>0.8</td></tr><tr><td/><td>Week 12</td><td>70</td><td>1.8</td><td>69</td><td>1.0</td><td>66</td><td>1.2</td><td>67</td><td>1.1</td><td>67</td><td>1.0</td><td>67</td><td>0.2</td></tr><tr><td>Uric Acid, mg/dL</td><td>Week 6</td><td>7.1</td><td>0.2</td><td>5.8</td><td>0.17</td><td>6.0*</td><td>0.22</td><td>5.1*</td><td>0.16</td><td>5.9*</td><td>0.26</td><td>4.7*</td><td>0.26</td></tr><tr><td/><td>Week 12</td><td>7.0</td><td>0.3</td><td>5.8</td><td>0.25</td><td>5.8*</td><td>0.20</td><td>4.9*</td><td>0.15</td><td>5.6*</td><td>0.28</td><td>4.6*</td><td>0.27</td></tr></tbody></table><table-wrap-foot><p>*<italic>p</italic> &#x0003c;0.05 compared to respective No-Intervention control group</p></table-wrap-foot></table-wrap>
</p><p id="Par14">Serum UA concentrations were similar at baseline (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), in all the groups (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05). In a male-to-male and female-to-female comparison, the data in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> show that in PA group, at week-6, males had -15&#x000a0;% and females had -12&#x000a0;% lower UA than those in NI (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). At week-12, male and female participants of PA had -17 and -16&#x000a0;% lower concentrations, respectively, those in NI (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> also shows that, at week-6, serum UA in male and female participants of AA were -17 and -19&#x000a0;% less than in NI (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). At week-12, UA was further reduced up to -20 and -21&#x000a0;% in males and females, respectively, in AA.</p><p id="Par15">Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref> shows comparison with respect to baseline. At week-6, drop in serum UA concentration in male (1&#x000a0;%) and female (2&#x000a0;%) participants of NI was insignificant (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05). In the almonds-intervention groups, there was a significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) drop in UA; around -13&#x000a0;% in males of both PA and AA, and -11 and -16&#x000a0;% in females of PA and AA, respectively.<fig id="Fig1"><label>Fig. 1</label><caption><p>Percentage change in serum uric acid (UA) from baseline, at week-6 (<bold>a</bold>) and week-12 (<bold>b</bold>), in coronary artery disease patients randomized in no-intervention (NI), Pakistani almond (PA) or American almond (AA) groups. Values are mean&#x02009;&#x000b1;&#x02009;SEM; <italic>n</italic>&#x02009;=&#x02009;34 in NI group, <italic>n</italic>&#x02009;=&#x02009;38 in PA group and <italic>n</italic>&#x02009;=&#x02009;41 in AA group</p></caption><graphic xlink:href="12937_2016_195_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par16">Figure <xref rid="Fig1" ref-type="fig">1b</xref> compares UA concentrations of baseline and intervention. At week-12, there was negligible (-3 and -2&#x000a0;%) drop in males and females of NI, while the drop in PA and AA was significant (-16 and -14&#x000a0;% in males and females of PA and -18&#x000a0;% in both males and females of AA; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></sec><sec id="Sec6" sec-type="discussion"><title>Discussion</title><p id="Par17">To the best of our knowledge, this is the first almond-intervention study on CAD patients reporting UA reduction. Previously, in rat model, dietary almonds prevented high-fat diet-induced hyperuricemia, followed by reduced nitric oxide (NO) production via endothelial NO synthase (eNOS) inhibition resulting in improved vascular function of isolated aorta [<xref ref-type="bibr" rid="CR13">13</xref>]. So, from results in CAD patients, we can also infer probable vascular protection.</p><p id="Par18">Serum UA may be considered as a biomarker for vascular function [<xref ref-type="bibr" rid="CR15">15</xref>]. Anticipated pathways of UA-induced vascular dysfunction [<xref ref-type="bibr" rid="CR16">16</xref>] include, but are not limited to: pro-oxidative affect, whereby UA decomposes and generates free radicals; pro-inflammatory affect via association with biomarkers like interleukins (IL-1, IL-6, IL-10, IL-18), tumor necrosis factor (TNF-&#x003b1;) and C-reactive proteins (CRP); endogenous stimulation of innate immunity; changing expression of endothelin-1; promoting angiotensin-II production; inducing smooth muscle cell proliferation; and direct reaction with, and depletion of NO.</p><p id="Par19">Almond supplementation is shown to influence some of these parameters. Although, Jenkins et al. report no effect of almonds on CRP, BP or pulmonary NO [<xref ref-type="bibr" rid="CR17">17</xref>]; Rajaram et al. [<xref ref-type="bibr" rid="CR18">18</xref>] observed significant reduction in CRP. Two studies in diabetic patients [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], report a drop in CRP accompanied by anti-inflammation via IL-6 reduction; while Liu et al. [<xref ref-type="bibr" rid="CR20">20</xref>], also reports decrease in TNF-&#x003b1; by dietary almonds. Bhardwaj et al. [<xref ref-type="bibr" rid="CR21">21</xref>], also demonstrated drop in CRP, accompanied by improved flow-mediated dilatation, indicating improved endothelial function. But more recently, Chen et al. [<xref ref-type="bibr" rid="CR22">22</xref>] reported no effect of almond supplementation on vascular function, CRP, TNF-&#x003b1; and even the lipid profile of CAD patients in a randomized cross-over clinical trial. This may be due to the drug therapy which could mimic the effect of intervention. Decrease in vascular cell adhesion molecules was observe, which may indicate improvement in vascular function. Trials longer than four to six weeks may be able to offer detectible improvements in vascular function of CAD patients.</p><p id="Par20">Almonds are rich in L-arginine, which is a precursor of NO. Supplementation of L-synthetic arginine reverses hyperuricemia-induced hypertension in rats [<xref ref-type="bibr" rid="CR23">23</xref>]. However, BP of participants in our trial remained fairly constant during twelve weeks. Reason being, almost all CAD patients were on anti-hypertensive medications, and baseline BP was within normal ranges.</p><p id="Par21">The precise underling mechanisms of almonds action on serum uric acid remains to be explored. Certain limitations of our trial include the following. The inclusion criteria included only those CAD patients, who had optimal LDL-C and sub-optimal HDL-C. This may not truly represent the CAD population in general. Sample size was calculated for observable improvements in serum HDL.</p></sec><sec id="Sec7" sec-type="conclusion"><title>Conclusion</title><p id="Par22">Almond supplementation can provide holistic benefits to CAD patients. Previous clinical studies have almonds&#x02019; potential in ameliorating dyslipidemia, the current investigation adds to its vasculo-protective effects, by presenting prominent reduction in serum uric acid.</p></sec><sec id="Sec8"><title>Abbreviations</title><p id="Par23">AA, American almonds; BP, blood pressure; CAD, coronary artery disease; CVD, cardiovascular diseases; NI, no intervention; NO, nitric oxide; PA, Pakistani almonds; UA, uric acid</p></sec></body><back><ack><sec id="FPar1"><title>Funding</title><p id="Par24">This study was supported by the Higher Education Commission through Indigenous PhD scholarship grant. The Higher Education Commission had no role in the design, analysis or writing of this article.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par25">The data supporting the conclusions of this article are included within the article (table and figure).</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p id="Par26">AHG designed and guided research (project conception, development of overall research plan, and study oversight). HJ conducted research (hands-on conduct of the experiments and data collection) and analyzed the data and drafted the manuscript. FATS was the primary Cardiologist involved in dealing with patients. FA helped in designing of the clinical trial and statistical analysis. JA, SG and MM were involved in patients&#x02019; recruitment and maintaining follow-up visits, blood collection, processing and preservation. AHG, FATS and JA helped in refining the manuscript. All authors have read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p id="Par27">The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p id="Par28">The written informed consent signed by all the participants, also included the consent for publication.</p></sec><sec id="FPar6"><title>Ethical approval and consent to participate</title><p id="Par29">This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human patients were approved by the Ethics Review Committee, Aga Khan University (Application ID: 2230-Med-ERC-12). Written informed consent (in both languages i.e. English and Urdu) was obtained from all patients.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermayr</surname><given-names>RP</given-names></name><name><surname>Temml</surname><given-names>C</given-names></name><name><surname>Gutjahr</surname><given-names>G</given-names></name><name><surname>Knechtelsdorfer</surname><given-names>M</given-names></name><name><surname>Oberbauer</surname><given-names>R</given-names></name><name><surname>Klauser-Braun</surname><given-names>R</given-names></name></person-group><article-title>Elevated uric acid increases the risk for kidney disease</article-title><source>J Am Soc Nephrol</source><year>2008</year><volume>19</volume><fpage>2407</fpage><lpage>2413</lpage><pub-id pub-id-type="doi">10.1681/ASN.2008010080</pub-id><pub-id pub-id-type="pmid">18799720</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriarity</surname><given-names>JT</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Iribarren</surname><given-names>C</given-names></name><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Rosamond</surname><given-names>WD</given-names></name></person-group><article-title>Serum uric acid and risk of coronary heart disease: atherosclerosis risk in communities (ARIC) study</article-title><source>Ann Epidemiol</source><year>2000</year><volume>10</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/S1047-2797(99)00037-X</pub-id><pub-id pub-id-type="pmid">10813506</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isik</surname><given-names>T</given-names></name><name><surname>Ayhan</surname><given-names>E</given-names></name><name><surname>Ergelen</surname><given-names>M</given-names></name><name><surname>Uyarel</surname><given-names>H</given-names></name></person-group><article-title>Uric acid: a novel prognostic marker for cardiovascular disease</article-title><source>Int J Cardiol</source><year>2012</year><volume>156</volume><fpage>328</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2012.01.095</pub-id><pub-id pub-id-type="pmid">22357419</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos</surname><given-names>MJ</given-names></name><name><surname>Koudstaal</surname><given-names>PJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name></person-group><article-title>Uric acid is a risk factor for myocardial infarction and stroke the Rotterdam study</article-title><source>Stroke</source><year>2006</year><volume>37</volume><fpage>1503</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000221716.55088.d4</pub-id><pub-id pub-id-type="pmid">16675740</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Guevara</surname><given-names>JP</given-names></name><name><surname>Kim</surname><given-names>KM</given-names></name><name><surname>Choi</surname><given-names>HK</given-names></name><name><surname>Heitjan</surname><given-names>DF</given-names></name><name><surname>Albert</surname><given-names>DA</given-names></name></person-group><article-title>Hyperuricemia and coronary heart disease: a systematic review and meta-analysis</article-title><source>Arthritis Care Res</source><year>2010</year><volume>62</volume><fpage>170</fpage><lpage>180</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Alderman</surname><given-names>MH</given-names></name></person-group><article-title>Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992</article-title><source>JAMA</source><year>2000</year><volume>283</volume><fpage>2404</fpage><lpage>2410</lpage><pub-id pub-id-type="doi">10.1001/jama.283.18.2404</pub-id><pub-id pub-id-type="pmid">10815083</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Iribarren</surname><given-names>C</given-names></name><name><surname>Gross</surname><given-names>MD</given-names></name><name><surname>Comstock</surname><given-names>GW</given-names></name><name><surname>Cutler</surname><given-names>RG</given-names></name></person-group><article-title>Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?</article-title><source>Atherosclerosis</source><year>2000</year><volume>148</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(99)00214-2</pub-id><pub-id pub-id-type="pmid">10580179</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>JG</given-names></name><name><surname>Juzwishin</surname><given-names>KD</given-names></name><name><surname>Eiriksdottir</surname><given-names>G</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name></person-group><article-title>Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis</article-title><source>PLoS Med</source><year>2005</year><volume>2</volume><fpage>236</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0020076</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athyros</surname><given-names>VG</given-names></name><name><surname>Mikhailidis</surname><given-names>DP</given-names></name><name><surname>Liberopoulos</surname><given-names>EN</given-names></name><name><surname>Kakafika</surname><given-names>AI</given-names></name><name><surname>Karagiannis</surname><given-names>A</given-names></name><name><surname>Papageorgiou</surname><given-names>AA</given-names></name><name><surname>Tziomalos</surname><given-names>K</given-names></name><name><surname>Ganotakis</surname><given-names>ES</given-names></name><name><surname>Elisaf</surname><given-names>M</given-names></name></person-group><article-title>Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome a subgroup analysis of the GREek atorvastatin and coronary heart disease evaluation (GREACE) study</article-title><source>Nephrol Dial Transplant</source><year>2007</year><volume>22</volume><fpage>118</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfl538</pub-id><pub-id pub-id-type="pmid">16998214</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Impact of allopurinol on heart function, endothelial function and indexes of inflammation in patients with acute myocardial infarction</article-title><source>China Pharmacy</source><year>2006</year><volume>24</volume><fpage>018</fpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ternus</surname><given-names>M</given-names></name><etal/></person-group><article-title>Qualified health claim for nuts and heart disease prevention: development of consumer-friendly language</article-title><source>Nutr Today</source><year>2006</year><volume>41</volume><fpage>62</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1097/00017285-200603000-00005</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berryman</surname><given-names>CE</given-names></name><name><surname>Preston</surname><given-names>AG</given-names></name><name><surname>Karmally</surname><given-names>W</given-names></name><name><surname>Deckelbaum</surname><given-names>RJ</given-names></name><name><surname>Kris-Etherton</surname><given-names>PM</given-names></name></person-group><article-title>Effects of almond consumption on the reduction of LDL-cholesterol: a discussion of potential mechanisms and future research directions</article-title><source>Nutr Rev</source><year>2011</year><volume>69</volume><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2011.00383.x</pub-id><pub-id pub-id-type="pmid">21457263</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamshed</surname><given-names>H</given-names></name><name><surname>Gilani</surname><given-names>AH</given-names></name></person-group><article-title>Almonds inhibit dyslipidemia and vascular dysfunction in rats through multiple pathways</article-title><source>J Nutr</source><year>2014</year><volume>144</volume><fpage>1768</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.3945/jn.114.198721</pub-id><pub-id pub-id-type="pmid">25332475</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamshed</surname><given-names>H</given-names></name><name><surname>Sultan</surname><given-names>FA</given-names></name><name><surname>Iqbal</surname><given-names>R</given-names></name><name><surname>Gilani</surname><given-names>AH</given-names></name></person-group><article-title>Dietary almonds increase serum HDL cholesterol in coronary artery disease patients in a randomized controlled trial</article-title><source>J Nutr.</source><year>2015</year><volume>145</volume><fpage>2287</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.3945/jn.114.207944</pub-id><pub-id pub-id-type="pmid">26269239</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamshed</surname><given-names>H</given-names></name><name><surname>Arslan</surname><given-names>J</given-names></name><name><surname>Gilani</surname><given-names>AH</given-names></name></person-group><article-title>Cholesterol-cholate-butterfat diet offers multi-organ dysfunction in rats</article-title><source>Lipids Health Dis</source><year>2014</year><volume>13</volume><fpage>194</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-13-194</pub-id><pub-id pub-id-type="pmid">25515296</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Kang</surname><given-names>DH</given-names></name><name><surname>Feig</surname><given-names>D</given-names></name><name><surname>Kivlighn</surname><given-names>S</given-names></name><name><surname>Kanellis</surname><given-names>J</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Tuttle</surname><given-names>KR</given-names></name><name><surname>Rodriguez-Iturbe</surname><given-names>B</given-names></name><name><surname>Herrera-Acosta</surname><given-names>J</given-names></name><name><surname>Mazzali</surname><given-names>M</given-names></name></person-group><article-title>Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?</article-title><source>Hypertension</source><year>2003</year><volume>41</volume><fpage>1183</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000069700.62727.C5</pub-id><pub-id pub-id-type="pmid">12707287</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>DJ</given-names></name><name><surname>Kendall</surname><given-names>CW</given-names></name><name><surname>Marchie</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>TL</given-names></name><name><surname>Connelly</surname><given-names>PW</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>Haight</surname><given-names>JS</given-names></name><name><surname>Faulkner</surname><given-names>D</given-names></name><name><surname>Vidgen</surname><given-names>E</given-names></name><name><surname>Lapsley</surname><given-names>KG</given-names></name><name><surname>Spiller</surname><given-names>GA</given-names></name></person-group><article-title>Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein (a), homocysteine, and pulmonary nitric oxide a randomized, controlled, crossover trial</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>1327</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000028421.91733.20</pub-id><pub-id pub-id-type="pmid">12221048</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajaram</surname><given-names>S</given-names></name><name><surname>Connell</surname><given-names>KM</given-names></name><name><surname>Joan</surname><given-names>S</given-names></name></person-group><article-title>Effect of almond-enriched high-monounsaturated fat diet on selected markers of inflammation: a randomised, controlled, crossover study</article-title><source>Br J Nutr</source><year>2010</year><volume>103</volume><fpage>907</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1017/S0007114509992480</pub-id><pub-id pub-id-type="pmid">19874636</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweazea</surname><given-names>KL</given-names></name><name><surname>Johnston</surname><given-names>CS</given-names></name><name><surname>Ricklefs</surname><given-names>KD</given-names></name><name><surname>Petersen</surname><given-names>KN</given-names></name></person-group><article-title>Almond supplementation in the absence of dietary advice significantly reduces C-reactive protein in subjects with type 2 diabetes</article-title><source>J Funct Foods</source><year>2014</year><volume>10</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2014.06.024</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JF</given-names></name><etal/></person-group><article-title>The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial</article-title><source>Eur J Nutr</source><year>2013</year><volume>52</volume><fpage>927</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1007/s00394-012-0400-y</pub-id><pub-id pub-id-type="pmid">22722891</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>R</given-names></name><name><surname>Manivannan</surname><given-names>S</given-names></name><name><surname>Gharib</surname><given-names>W</given-names></name><name><surname>Warden</surname><given-names>B</given-names></name><name><surname>Hobbs</surname><given-names>G</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name></person-group><article-title>Acute effects of diets rich in almonds and walnuts on endothelial function in humans</article-title><source>Circulation</source><year>2012</year><volume>126</volume><fpage>A14738</fpage></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Holbrook</surname><given-names>M</given-names></name><name><surname>Duess</surname><given-names>MA</given-names></name><name><surname>Dohadwala</surname><given-names>MM</given-names></name><name><surname>Hamburg</surname><given-names>NM</given-names></name><name><surname>Asztalos</surname><given-names>BF</given-names></name><name><surname>Milbury</surname><given-names>PE</given-names></name><name><surname>Blumberg</surname><given-names>JB</given-names></name><name><surname>Vita</surname><given-names>JA</given-names></name></person-group><article-title>Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial</article-title><source>Nutr J</source><year>2015</year><volume>14</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1186/s12937-015-0049-5</pub-id><pub-id pub-id-type="pmid">26080804</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Lozada</surname><given-names>LG</given-names></name><name><surname>Tapia</surname><given-names>E</given-names></name><name><surname>L&#x000f3;pez-Molina</surname><given-names>R</given-names></name><name><surname>Nepomuceno</surname><given-names>T</given-names></name><name><surname>Soto</surname><given-names>V</given-names></name><name><surname>Avila-Casado</surname><given-names>C</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Herrera-Acosta</surname><given-names>J</given-names></name><name><surname>Franco</surname><given-names>M</given-names></name></person-group><article-title>Effects of acute and chronic L-arginine treatment in experimental hyperuricemia</article-title><source>Am J Physiol-Renal Physiol</source><year>2007</year><volume>292</volume><fpage>1238</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00164.2006</pub-id></element-citation></ref></ref-list></back></article>